Frequency and impact of symptoms experienced by patients with systemic sclerosis: results from a Canadian National Survey

被引:201
作者
Bassel, Marielle [1 ,2 ]
Hudson, Marie [3 ,4 ,5 ]
Taillefer, Suzanne S. [5 ]
Schieir, Orit [6 ]
Baron, Murray [3 ,5 ]
Thombs, Brett D. [1 ,2 ,3 ,4 ,5 ,7 ]
机构
[1] Jewish Gen Hosp, Dept Psychiat, Montreal, PQ H3T 1E4, Canada
[2] McGill Univ, Dept Psychiat, Montreal, PQ, Canada
[3] McGill Univ, Dept Med, Div Rheumatol, Montreal, PQ, Canada
[4] Jewish Gen Hosp, Ctr Clin Epidemiol & Community Studies, Montreal, PQ H3T 1E4, Canada
[5] Jewish Gen Hosp, Dept Med, Div Rheumatol, Montreal, PQ H3T 1E4, Canada
[6] Univ Toronto, Dalla Lana Sch Publ Hlth, Dept Epidemiol, Toronto, ON, Canada
[7] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada
基金
加拿大健康研究院;
关键词
Systemic sclerosis; Scleroderma; Fatigue; Hand function; Sleep problems; Pruritus; Quality of life; QUALITY-OF-LIFE; DISEASE; SCLERODERMA; PREVALENCE; HEALTH; DEPRESSION; FATIGUE;
D O I
10.1093/rheumatology/keq310
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Methods. A total of 464 persons with SSc responded to the Canadian Scleroderma Patient Survey of Health Concerns and Research Priorities, including questions regarding the frequency and impact of 69 SSc symptoms. Descriptive analyses were performed dichotomizing symptom frequencies as never or rarely vs sometimes, most of the time or always and symptom impact on daily activities as no or minimal impact vs moderate to severe impact. Results. The five highest rated symptoms in terms of frequency and moderate to severe impact on daily activities, respectively, were: fatigue (89 and 72%), RP (86 and 67%), hand stiffness (81 and 59%), joint pain (81 and 64%) and difficulty sleeping (76 and 59%). In addition to these symptoms, items related to decreased hand function (difficulty making a fist and difficulty holding objects) and pain (muscle pain and joint tenderness) were frequently endorsed and commonly associated with moderate to severe impact on daily activities. Conclusion. This study confirmed the importance for quality of life of core symptoms of SSc, such as pain, fatigue and limitations in hand function. It also identified areas with very little research, such as sleep problems, that appear to play important roles in daily functioning, and that merit more focused study.
引用
收藏
页码:762 / 767
页数:6
相关论文
共 20 条
  • [1] Clinical correlates of quality of life in systemic sclerosis measured with the world health organization disability assessment schedule II
    Hudson, Marie
    Thombs, Brett D.
    Steele, Russell
    Watterson, Rita
    Taillefer, Suzanne
    Baron, Murray
    [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2008, 59 (02): : 279 - 284
  • [2] Health-Related Quality of Life in Systemic Sclerosis: A Systematic Review
    Hudson, Marie
    Thombs, Brett D.
    Steele, Russell
    Panopalis, Pantelis
    Newton, Evan
    Baron, Murray
    [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (08): : 1112 - 1120
  • [3] KOEHN C, 2006, DETERMINING RES PRIO
  • [4] LI LC, 2005, CARE 3 ONLINE PATIEN
  • [5] Impact of digital ulcers on disability and health-related quality of life in systemic sclerosis
    Mouthon, L.
    Mestre-Stanislas, C.
    Berezne, A.
    Rannou, F.
    Guilpain, P.
    Revel, M.
    Pagnoux, C.
    Guillevin, L.
    Fermanian, J.
    Poiraudeau, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (01) : 214 - 217
  • [6] Ostojic P, 2006, Z RHEUMATOL, V65, P168, DOI 10.1007/s00393-006-0050-7
  • [7] Musculoskeletal rehabilitation in the person with scleroderma
    Poole, Janet L.
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2010, 22 (02) : 205 - 212
  • [8] Prado Gilmar F, 2002, Sleep Med, V3, P341, DOI 10.1016/S1389-9457(02)00013-8
  • [9] Prevalence and Clinical Correlates of Pruritus in Patients With Systemic Sclerosis
    Razykov, Ilya
    Thombs, Brett D.
    Hudson, Marie
    Bassel, Marielle
    Baron, Murray
    [J]. ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2009, 61 (12): : 1765 - 1770
  • [10] Richards HL., 2004, PSYCHOL HEALTH MED, V9, P29, DOI DOI 10.1080/13548500310001637733